DATE: Thursday, April 29, 2021
TIME: 2:30 p.m.
LOCATION: Live via Zoom
ACPE CREDIT: Accredited for 1.0 contact hour (see below for instructions on how to claim credit)

Diana Le, PharmD

Diana Le, PharmD

PGY-1 Pharmacy Practice Resident
Loma Linda University School of Pharmacy

Learning Objectives:

Upon successful completion of this knowledge-based course pharmacists should be able to:

  1. Describe the pathophysiology of COVID-19 associated cytokine release syndrome
  2. Explain the mechanism of action of tocilizumab
  3. Review the literature regarding tocilizumab use in COVID-19
  4. Identify patients with COVID-19 who may benefit from tocilizumab

Claim your CPE Credit

To obtain 1.0 contact hour of continuing pharmacy education credit (0.1 CEU), participants must participate in the live activities, and logon to the CEimpact website to complete the exam and evaluation.

  1. Click on https://learn.ceimpact.com and log in to CEImpact.
  2. If you are new to the site, click on Create an account before logging in.
  3. Enter the course code (provided at the end of the lecture) in the text box on the left of the screen and click Submit.
  4. Click on My Courses (on the left of the screen) to locate the course.
  5. Click on the course title to access the course.
  6. Complete the exam and evaluation as prompted and click Submit.
  7. The course will move to the Completed tab under My Courses.
  8. The CPE Statement of Credit will be available on CPE Monitor, www.MyCPEMonitor.net.

ACPELOGOCEimpact is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. 

UAN: 0107-9999-21-159-L01-P       |     0.1 CEUs/1.0 Hrs.
Live Date:  April 29th, 2021
Live Expiration:  May 29th, 2021

Faculty Disclosure: Diana Le does not report any actual or potential conflicts of interest in relation to this continuing pharmacy education course. 

Activity Format: Live

Financial Support: None

Activity Fee: This course is available for free.